1 active not recruiting, 1 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow response-adapted radiation: new trials by email Literature Review of response-adapted radiation trials Research Report on response-adapted radiation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment Brentuximab Vedotin for Injection, response-adapted radiation, Doxorubicin - Classical Hodgkin Lymphoma, Child | Phase 2 / Phase 3 | Recruiting | Children's Cancer Group, China | 96 | 2024-09-25 | 2026-03-19 |
| Orelabrutinib Followed by Response-adapted Ultra-low Dose 4Gy Radiation as First-line Treatment of MALT Lymphoma Orelabrutinib, response-adapted radiation - Lymphoma, B-Cell, Marginal Zone | Phase 2 | Active not recruiting | Fudan University | 50 | 2024-09-10 | 2026-02-27 |
Lymphoma, B-Cell, Marginal Zone (1)
Children's Cancer Group, China (1) · Fudan University (1)
China (2)
Rong Tao (1)